Lund University

lu.se

Total trials

292

Active

55

Phase 3

14

Total enrollment

186,230

Read this sponsor's pipeline like an analyst.

Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.

~15-30 sec · cached for 24h

Pipeline matrix

Showing 13 of 13 active programs · click any cell for trials

InterventionEarly Phase 1Phase 1Phase 2Phase 3Phase 4N/ATotal
177Lu-DOTATOC1
Capecitabine1
Pivmecillinam and amoxicillin/clavulanic acid1
Standard treatment, ciprofloxacin, trimethoprim/sulfamethoxazole or ertapenem depending on susceptibility1
Simvastatin 40mg1
epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumab1
epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumab1
Fluorouracil1
Oxaliplatin1
Irinotecan1
Pemigatinib1
Retifanlimab1
Active medication1

Next readouts

  • 2024-05-31
  • 2026-10-01
  • 2026-11-30
  • 2027-01-26
  • 2027-09-01
  • 2027-12-31
  • 2035-09

Top conditions

  • Healthy10
  • Obesity10
  • Type 2 Diabetes10
  • Metabolic Syndrome8
  • Celiac Disease in Children5
  • Breast Cancer5
  • Healthy Subjects5
  • Depression4

Frequently asked questions about Lund University

How many clinical trials does Lund University have on ClinicalTrials.gov?
Lund University is listed as the lead sponsor on 292 clinical trials in ClinicalTrials.gov, 55 of which are currently active (recruiting, enrolling, or ongoing).
How many of Lund University's trials are in Phase 3?
14 of Lund University's trials are in Phase 3, spread across 13 active drug programs.
What therapeutic areas does Lund University focus on?
Lund University's most-studied conditions on ClinicalTrials.gov are Healthy, Obesity, Type 2 Diabetes, Metabolic Syndrome, Celiac Disease in Children.
When are Lund University's next clinical trial readouts?
Lund University has 7 upcoming primary-completion readouts tracked here; the soonest is “Acoustic and Vestibular Noise as Possible Non-pharmacological Treatment of ADHD in School Children”, expected around 2024-05-31.